The U.S. Withdraws from WHO Again — and the World Will Feel It

The World Health Organization has confirmed it received formal notification of the United States' withdrawal, calling the decision one that makes "both the United States and the world less safe." The move, which echoes a similar withdrawal attempt during the first Trump administration, sets off a chain of institutional, financial, and diplomatic consequences that will take years to fully materialize — and that no single press release can adequately capture.

The WHO noted that the notification raises issues significant enough to be taken up by the WHO Executive Board at its regular meeting beginning February 2, and later by the World Health Assembly at its annual meeting in May 2026. That timeline matters. It means the world's premier global health body will spend the better part of a year in a kind of institutional limbo, negotiating the terms of an absence from its single largest donor state while simultaneously trying to manage ongoing disease surveillance, outbreak response, and the slow-moving machinery of international health diplomacy.

The United States has historically been the WHO's largest financial contributor, accounting for roughly 18 percent of the organization's total assessed and voluntary contributions. Losing that funding does not simply mean a smaller budget. It means the WHO must either dramatically restructure its programs or become more dependent on a narrower set of donors, including philanthropic actors like the Bill and Melinda Gates Foundation and sovereign contributors like Germany and the European Union. That shift in funding architecture changes who has leverage over WHO priorities — a second-order consequence that rarely gets discussed in the immediate aftermath of a withdrawal announcement.

When the U.S. pulled back during the first Trump term, the Biden administration reversed course almost immediately upon taking office in January 2021, rejoining the organization and restoring funding. That reversal took months to fully implement and left gaps in U.S. participation during the critical early phase of COVID-19's global spread. The current withdrawal, if it follows through to completion, would take effect one year after formal notification under WHO constitutional rules — meaning the earliest the U.S. could be fully out is sometime in 2026, which is precisely when the World Health Assembly is scheduled to address the matter.

The deeper systemic risk here is not just financial. The United States provides not only money but scientific capacity, laboratory networks, and epidemiological expertise that are woven into WHO's operational fabric. The U.S. Centers for Disease Control and Prevention has long maintained staff embedded within WHO programs, contributing to everything from polio eradication efforts in South Asia to Ebola response protocols in Central Africa. Pulling that human infrastructure out of the system does not leave a clean hole — it leaves frayed connections, broken data pipelines, and institutional knowledge that walks out the door.

There is also a geopolitical dimension that deserves serious attention. China has been steadily increasing its influence within WHO and other UN-affiliated bodies over the past decade. A diminished American presence creates space for that influence to expand further, shaping everything from pandemic treaty negotiations to the standards used in global pharmaceutical regulation. Critics of WHO have long argued the organization is too deferential to Beijing; withdrawing U.S. membership does nothing to fix that problem and arguably accelerates it.

For the 194 member states that remain inside the organization, the American withdrawal also sends a signal about the reliability of U.S. commitments to multilateral institutions more broadly. Countries that have structured their own health systems around WHO guidelines and U.S.-backed programs will be watching closely, recalibrating their assumptions about American partnership in ways that extend well beyond public health.

The WHO's statement was measured but pointed. The phrase "less safe" was not rhetorical flourish — it was a direct challenge to the logic that national interest is best served by stepping away from the table where global health rules are written. Whether that argument lands in Washington remains to be seen. What is already clear is that the February Executive Board meeting and the May 2026 World Health Assembly will be among the most consequential gatherings in the organization's recent history, and the decisions made there will shape the architecture of global health governance long after the political moment that triggered them has passed.